Clinical Trial Update: IVIg Plus Low Dose rhTPO for ITP in Pregnancy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating intravenous immunoglobulin plus low-dose recombinant human thrombopoietin for immune thrombocytopenia in pregnancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia
• Pregnancy-related Conditions Affecting Thrombocytes

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)
• low-dose recombinant human thrombopoietin (rhTPO)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia, Pregnancy Related | Phase 2 | Status: UNKNOWN